Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone. (Q45983716)
Jump to navigation
Jump to search
scientific article published on 2 June 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone. |
scientific article published on 2 June 2009 |
Statements
1 reference
Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone. (English)
1 reference
Serkan Yener
1 reference
Abdurrahman Comlekci
1 reference
Baris Akinci
1 reference
Tevfik Demir
1 reference
Faize Yuksel
1 reference
Mehmet Ali Ozcan
1 reference
Firat Bayraktar
1 reference
Sena Yesil
1 reference
2 June 2009
1 reference
1 reference
18
1 reference
266-271
1 reference
4
1 reference
Identifiers
1 reference
1 reference